Highlights
The sum of the parts case for DK still looks attractive even with weakness in the company’s key asset.
External risks have been mitigated for MITK, but slowing first-half growth has sparked investor concern.
NOMD is cheaper than it was when we recommended it last year — yet earnings are higher. At less than 10x free cash flow, the company simpl…